Armando J Ruiz-Justiz

Dr. Armando J Ruiz-Justiz

Ophthalmology, University of Puerto Rico, Medical Sciences Campus, San Juan, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SJShirley Jusino
Shirley Jusino
YRYainyrette Rivera-Rivera
Yainyrette Rivera-Rivera
CCCamille Chardón-Colón
Camille Chardón-Colón
Armando J Ruiz-JustizArmando J Ruiz-Justiz
Armando J Ruiz-Justiz
JVJaleisha Vélez-Velázquez
Jaleisha Vélez-Velázquez
HSHarold I. Saavedra
Harold I. Saavedra
E2F3 is a transcription factor that may initiate tumorigenesis if overexpressed. Previously, we demonstrated that E2F3 mRNA is overexpressed in breast cancer and that E2F3 overexpression results in centrosome amplification and unregulated mitosis, which can promote aneuploidy and chromosome instability to initiate and sustain tumors. Further, we demonstrated that E2F3 leads to overexpression of the mitotic regulator Shugoshin-1, which until recently had unknown roles in cancer. This study aims to evaluate the roles of E2F3 and Shugoshin-1 in breast cancer metastatic potential. Here we demonstrated that E2F3 and Shugoshin-1 silencing leads to reduced cell invasion and migration in two mesenchymal triple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and Hs578t). Moreover, E2F3 and Shugoshin-1 modulate the expression of epithelial-to-mesenchymal transition-associated genes such as Snail, E-Cadherin, and multiple matrix metalloproteinases. Furthermore, E2F3 depletion leads to reductions in tumor growth and metastasis in NOD-scid Gamma mice. Results from this study suggest a key role for E2F3 and a novel role for Shugoshin-1 in metastatic progression. These results can further help in the improvement of TNBC targeted therapies by interfering with pathways that intersect with the E2F3 and Shugoshin-1 signaling pathways.

29 June 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Armando J Ruiz-JustizArmando J Ruiz-Justiz
Armando J Ruiz-Justiz
VCVanessa Cruz-Villegas
Vanessa Cruz-Villegas
Stephen G. SchwartzStephen G. Schwartz
Stephen G. Schwartz
VVVíctor Manuel Villegas
Víctor Manuel Villegas
TMTimothy G. G. Murray
Timothy G. G. Murray
Purpose: To review the current literature on the combined use of cataract surgery (or lensectomy) and vitrectomy in pediatric patients, with a focus on clinical indications, surgical techniques, outcomes, and complications across various pediatric ocular pathologies. Methods: A narrative review of published studies addressing the use of combined lensectomy and vitrectomy (LV) in pediatric patients was conducted. Conditions discussed include congenital cataracts, ectopia lentis, retinopathy of prematurity (ROP), retinal detachment (RD), and persistent fetal vasculature (PFV). Key surgical considerations, visual and anatomical outcomes, and postoperative complications were examined. Results: The literature search yielded a total of 160 articles, of which 43 met the inclusion criteria and were included in this review. Although lens-sparing vitrectomy (LSV) is preferred in many pediatric cases to preserve accommodation and reduce complications, combined LV is often necessary in advanced or complex diseases. Studies have shown that combined LV can achieve favorable anatomical outcomes, but functional visual recovery remains variable and is affected by factors such as patient age, baseline ocular anatomy, and disease severity. Postoperative complications such as glaucoma, visual axis opacification (VAO), and intraocular lens (IOL) dislocation are more frequent with combined procedures and require long-term follow-up and rehabilitation. Conclusions: Combined cataract surgery (or lensectomy) and vitrectomy may represent a valuable strategy in the management of complex pediatric ocular conditions, particularly when individualized to the clinical context. Tailored surgical approaches are essential to optimize anatomic and functional outcomes. Further prospective studies and harmonized multicenter registries are needed to develop evidence-based principles that can guide individualized surgical decision-making in this unique patient population.

1 April 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Armando J Ruiz-JustizArmando J Ruiz-Justiz
Armando J Ruiz-Justiz
JCJuliana Cano‐Mejia
Juliana Cano‐Mejia
RFRohan Fernandes
Rohan Fernandes
Nanoparticle-based photothermal therapy (PTT) has been widely investigated in cancer therapy as a rapid and minimally invasive tumor ablation technique. In this treatment modality, the intrinsic phot...